中度高血糖与糖尿病对结核病免疫功能障碍的影响
该研究纳入南非、罗马尼亚、印度尼西亚和秘鲁的活动性结核病患者,比较糖尿病(HbA1c≥6.5%)、中度高血糖(HbA1c 5.7%至<6.5%)与单纯结核患者及健康对照者的全血转录组(RNA-seq,n=249)。结果显示糖尿病加重结核患者宿主转录组的基因表达改变,且中度高血糖合并结核者的转录组更接近糖尿病合并结核者而非单纯结核者,两组均表现为I型干扰素反应降低。
要点
- 糖尿病合并结核患者固有炎症基因表达增加而适应性免疫反应降低。
- 中度高血糖合并结核者的血转录组更接近糖尿病合并结核而非单纯结核。
- 糖尿病合并结核与中度高血糖合并结核患者I型干扰素反应均低于单纯结核患者。
核心结论
- 结核与糖尿病共病者转录组改变,表现为炎症增强但I型干扰素反应降低,提示免疫表型解偶联。
- 中度高血糖个体也存在类似的结核免疫功能障碍,可能影响结核易感性。
研究设计与样本
- 研究采集4个国家活动性结核患者全血样本,按糖尿病(HbA1c≥6.5%)、中度高血糖(HbA1c 5.7%至<6.5%)、单纯结核及健康对照分组。
- 采用RNA-seq(n=249)检测差异血基因表达。
主要发现
- 糖尿病增加结核患者宿主转录组基因表达改变幅度,固有炎症基因增加而适应性免疫反应降低。
- 中度高血糖合并结核患者血转录组比单纯结核患者更接近糖尿病合并结核患者。
- 糖尿病合并结核与中度高血糖合并结核患者I型干扰素反应均低于单纯结核患者。
临床怎么用
- 对结核患者应关注血糖状态,中度高血糖亦可能提示免疫功能障碍。
- 糖尿病合并结核患者可能存在炎症增强与I型干扰素反应降低的免疫失衡。
局限性
- 中度高血糖合并结核患者的结核病结局尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with diabetes have an increased risk of developing active tuberculosis (TB) and are more likely to have poor TB-treatment outcomes, which may impact on control of TB as the prevalence of diabetes is increasing worldwide. Blood transcriptomes are altered in patients with active TB relative to healthy individuals. The effects of diabetes and intermediate hyperglycemia (IH) on this transcriptomic signature were investigated to enhance understanding of immunological susceptibility in diabetes-TB comorbidity. METHODS: Whole blood samples were collected from active TB patients with diabetes (glycated hemoglobin [HbA1c] ≥6.5%) or IH (HbA1c = 5.7% to <6.5%), TB-only patients, and healthy controls in 4 countries: South Africa, Romania, Indonesia, and Peru. Differential blood gene expression was determined by RNA-seq (n = 249). RESULTS: Diabetes increased the magnitude of gene expression change in the host transcriptome in TB, notably showing an increase in genes associated with innate inflammatory and decrease in adaptive immune responses. Strikingly, patients with IH and TB exhibited blood transcriptomes much more similar to patients with diabetes-TB than to patients with only TB. Both diabetes-TB and IH-TB patients had a decreased type I interferon response relative to TB-only patients. CONCLUSIONS: Comorbidity in individuals with both TB and diabetes is associated with altered transcriptomes, with an expected enhanced inflammation in the presence of both conditions, but also reduced type I interferon responses in comorbid patients, suggesting an unexpected uncoupling of the TB transcriptome phenotype. These immunological dysfunctions are also present in individuals with IH, showing that altered immunity to TB may also be present in this group. The TB disease outcomes in individuals with IH diagnosed with TB should be investigated further.
引用
- Eckold C, Kumar V, Weiner J, et al. Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis. Clin Infect Dis. 2021. PMID: 32533832. doi:10.1093/cid/ciaa751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。